Several studies have attempted to predict the cancer risks associated with unclassified BRCA1 missense variants by performing bioinformatics analyses based on multiple sequence alignment data and protein structure predictions as well as clinical and family history data for some of these mutations. The gene discussed is BRCA1; the disease is cancer.